| Product NDC: | 13537-025 |
| Proprietary Name: | LBEL REGRESSION JOUR |
| Non Proprietary Name: | Avobenzone, Ensulizole, Octinoxate, and Oxybenzone |
| Active Ingredient(s): | .02; .01; .075; .02 g/g; g/g; g/g; g/g & nbsp; Avobenzone, Ensulizole, Octinoxate, and Oxybenzone |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 13537-025 |
| Labeler Name: | Ventura Corporation Ltd. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20120514 |
| Package NDC: | 13537-025-01 |
| Package Description: | 1 g in 1 PACKET (13537-025-01) |
| NDC Code | 13537-025-01 |
| Proprietary Name | LBEL REGRESSION JOUR |
| Package Description | 1 g in 1 PACKET (13537-025-01) |
| Product NDC | 13537-025 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Avobenzone, Ensulizole, Octinoxate, and Oxybenzone |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20120514 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Ventura Corporation Ltd. |
| Substance Name | AVOBENZONE; ENSULIZOLE; OCTINOXATE; OXYBENZONE |
| Strength Number | .02; .01; .075; .02 |
| Strength Unit | g/g; g/g; g/g; g/g |
| Pharmaceutical Classes |